Get startedLog in
    Picture of EvoNext Holdings SA logo

    EVE — EvoNext Holdings SA News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Evolva Holding: resveratrol part of novel combination therapy to be tested

    Picture of EvoNext Holdings SA logoEvoNext Holdings SA
    13/07/2016 06:01
    July 13 (Reuters) - Evolva Holding SA  EVE.S : 
    * Resveratrol part of novel combination therapy to be tested 
in a clinical trial for women with polycystic ovary syndrome 
 
Source text: http://bit.ly/29Wcebp 
Further company coverage:  EVE.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on EvoNext Holdings SA

    See all news